chlorothiazide sodium
NDC 25021-305 · Sagent Pharmaceuticals
FDA carries 2 listing records for this NDC; the most recent is shown.
Generic namechlorothiazide sodium
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)CHLOROTHIAZIDE SODIUM
Strength500 mg/18mL
Pharmacologic classIncreased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA
Packages
25021-305-20 — 1 VIAL in 1 CARTON (25021-305-20) / 18 mL in 1 VIAL
25021-305-66 — 1 VIAL in 1 CARTON (25021-305-66) / 18 mL in 1 VIAL
Billed under HCPCS
J1205 — Injection, chlorothiazide sodium, per 500 mg Medicare Part B payment limit (ASP + 6%): $77.77
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0517-1820 — Chlorothiazide Sodium, 47335-330 — CHLOROTHIAZIDE SODIUM, 63323-658 — CHLOROTHIAZIDE SODIUM, 68083-614 — Chlorothiazide sodium